Next Article in Journal
Development of a Non-Peptide Angiotensin II Type 1 Receptor Ligand by Structural Modification of Olmesartan as a Biased Agonist
Next Article in Special Issue
Hyperpolarized Xenon-129: A New Tool to Assess Pulmonary Physiology in Patients with Pulmonary Fibrosis
Previous Article in Journal
Developing In Vitro Models to Define the Role of Direct Mitochondrial Toxicity in Frequently Reported Drug-Induced Rhabdomyolysis
 
 
Article

Article Versions Notes

Biomedicines 2023, 11(5), 1483; https://doi.org/10.3390/biomedicines11051483
Action Date Notes Link
article html file updated 26 August 2026 00:04 CEST Update https://www.mdpi.com/2227-9059/11/5/1483/html
article html file updated 6 September 2025 06:58 CEST Update -
article html file updated 22 August 2025 20:55 CEST Update -
article html file updated 19 May 2023 13:23 CEST Original file -
article supplementary file uploaded. 19 May 2023 13:22 CEST - https://www.mdpi.com/2227-9059/11/5/1483#supplementary
article pdf uploaded. 19 May 2023 13:22 CEST Version of Record https://www.mdpi.com/2227-9059/11/5/1483/pdf
article xml uploaded. 19 May 2023 13:22 CEST Update https://www.mdpi.com/2227-9059/11/5/1483/xml
article xml file uploaded 19 May 2023 13:22 CEST Original file -
Back to TopTop